1-3 of 3
Lionel Galicier
Close
Sort by
Journal Articles

Higher rate of progression in HIV – than in HIV + patients after rituximab for HHV8 + multicentric Castleman disease

Clinical Trials & Observations
Camille Rasmussen, Laurence Gérard, Jehane Fadlallah, Emilie Corvilain, Lionel Galicier, Véronique Meignin, Eric Oksenhendler, David Boutboul
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5663–5669.
https://doi.org/10.1182/bloodadvances.2023010316
Published: 2023
Includes: Supplemental data
Journal Articles

Characteristics of circulating KSHV-infected viroblasts during active KSHV + multicentric Castleman disease

Gregoire Martin de Frémont, Anthony Vanjak, Zineb Sbihi, Silene Knapp, Margaux Garzaro, Marwa Chbihi, Benjamin Fournier, Justine Poirot, Antoine Dossier, Marc-Antoine Silvestrini, Juliette Villemonteix, Véronique Meignin, Lionel Galicier, Rémi Bertinchamp, Jerome Le Goff, Maud Salmona, Edouard Flamarion, Charles Cassius, Celeste Lebbé, Anne Marie Ronchetti, Sylvain Latour, Eric Oksenhendler, Guislaine Carcelain, David Boutboul
Journal: Blood Advances
Blood Adv (2023) 7 (9): 1682–1691.
https://doi.org/10.1182/bloodadvances.2022008456
Published: 2023
Includes: Supplemental data
Journal Articles

Autoimmune hypoglycemia expands the biological spectrum of HHV8 + multicentric Castleman disease

Clinical Trials & Observations
Pierre Arnautou, Martine Auclair, Soraya Fellahi, Clara Bouché, Claire Fieschi, Elias Barrak, Viviane Queyrel-Moranne, Lucy Chaillous, Nicolas Blin, Marion Malphettes, Jehane Fadlallah, Remi Bertinchamp, Laurence Gérard, Djaouida Bengoufa, Lionel Galicier, Eric Oksenhendler, Corinne Vigouroux, David Boutboul
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1848–1852.
https://doi.org/10.1182/bloodadvances.2020002801
Published: 2021
Includes: Supplemental data